Retraction

Effects of Combined Inhibition of STAT3 and VEGFR2 Pathways on the Radiosensitivity of Non-Small-Cell Lung Cancer Cells

Retraction Details

Citations (11)

11
Total Citations
2
Post-Retraction
(18.2%)
9
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
0 After 2+ years
264 Days since retraction (latest)
Retraction Note: MicroRNA-29 mediates anti-inflammatory effects and alleviation of allergic responses and symptoms in mice with allergic rhinitis
Jia Wang, Jinshu Yin, Hong Peng et al. (4 authors)
Allergy Asthma and Clinical Immunology Open Access
Published: Jun 2023
264 days after retraction
FOXK1 regulates epithelial-mesenchymal transition and radiation sensitivity in nasopharyngeal carcinoma via the JAK/STAT3 signaling pathway
Liqun Duan, Jinlong Huang, Yong Zhang et al. (8 authors)
Genes & Genomics
Published: Apr 2023
3 citations
201 days after retraction
Low Temperature Plasma Suppresses Lung Cancer Cells Growth via VEGF/VEGFR2/RAS/ERK Axis
Yuanyuan Zhou, Yan Zhang, Jie Bao et al. (5 authors)
Molecules Open Access
Published: Sep 2022
7 citations
10 days before retraction
CRISPR‐mediated knockout of VEGFR2/KDR inhibits cell growth in a squamous thyroid cancer cell line
Ming‐Lin Tsai, Chia‐Hwa Lee, Li‐Chi Huang et al. (9 authors)
FEBS Open Bio Open Access
Published: Mar 2022
9 citations
186 days before retraction
Radiation Sensitizers
Mansi K. Aparnathi, Sami Ul Haq, Zishan Allibhai et al. (5 authors)
Medical radiology
Published: Jan 2022
1 citation
265 days before retraction
The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage
Sarmishtha De, Elise Holvey-Bates, K. Mahen et al. (5 authors)
Proceedings of the National Academy of Sciences Open Access
Published: Nov 2021
68 citations
309 days before retraction
A novel role for apatinib in enhancing radiosensitivity in non-small cell lung cancer cells by suppressing the AKT and ERK pathways
Lin Li, Yuexian Li, Huawei Zou
PeerJ Open Access
Published: Oct 2021
3 citations
330 days before retraction
Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself
Qiankun Yang, Tong Chen, Shi-Qi Wang et al. (5 authors)
Angiogenesis
Published: Apr 2020
39 citations
882 days before retraction
HIF-1 signaling: A key orchestrator of cancer radioresistance
Ruixue Huang, Ping‐Kun Zhou
Radiation Medicine and Protection Open Access
Published: Mar 2020
42 citations
936 days before retraction
Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma
Junbin Liao, Huilin Jin, Shaoqiang Li et al. (11 authors)
Journal of Experimental & Clinical Cancer Research Open Access
Published: Nov 2019
59 citations
1052 days before retraction
Quick Stats
Total Citations: 11
Years Since Retraction: 3.2 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers